PUBLISHER: Lucintel | PRODUCT CODE: 1538540
PUBLISHER: Lucintel | PRODUCT CODE: 1538540
Self-Administered Parenteral Trends and Forecast
The future of the global self-administered parenteral market looks promising with opportunities in the cardiovascular disease, diabetes, osteoporosis, pain management, and hormone replacement markets. The global self-administered parenteral market is expected to grow with a CAGR of 5.5% from 2024 to 2030. The major drivers for this market are growing significance of specialty drugs & biologics, increasing acceptance of options for home-based therapy, and growing use of smart injection tools.
A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.
Self-Administered Parenteral by Segment
The study includes a forecast for the global self-administered parenteral by product type, usage, distribution channel, application, and region.
List of Self-Administered Parenteral Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies self-administered parenteral companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the self-administered parenteral companies profiled in this report include-
Self-Administered Parenteral Market Insights
Lucintel forecasts that pre-filled syringe is expected to witness the highest growth over the forecast period due to its growing demand for practical and safe medicine delivery systems.
Within this market, pain management is expected to witness the highest growth over the forecast period.
APAC is expected to witness the highest growth over the forecast period.
Features of the Global Self-Administered Parenteral Market
Market Size Estimates: Self-administered parenteral market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Self-administered parenteral market size by various segments, such as by product type, usage, distribution channel, application, and region in terms of value ($B).
Regional Analysis: Self-administered parenteral market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different product types, usages, distribution channels, applications, and regions for the self-administered parenteral market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the self-administered parenteral market.
Analysis of competitive intensity of the industry based on Porter's Five Forces model.
FAQ
Q1. What is the growth forecast for self-administered parenteral market?
Answer: The global self-administered parenteral market is expected to grow with a CAGR of 5.5% from 2024 to 2030.
Q2. What are the major drivers influencing the growth of the self-administered parenteral market?
Answer: The major drivers for this market are growing significance of specialty drugs & biologics, increasing acceptance of options for home-based therapy, and growing use of smart injection tools.
Q3. What are the major segments for self-administered parenteral market?
Answer: The future of the self-administered parenteral market looks promising with opportunities in the cardiovascular disease, diabetes, osteoporosis, pain management, and hormone replacement markets.
Q4. Who are the key self-administered parenteral market companies?
Answer: Some of the key self-administered parenteral companies are as follows:
Q5. Which self-administered parenteral market segment will be the largest in future?
Answer: Lucintel forecasts that pre-filled syringe is expected to witness the highest growth over the forecast period due to its growing demand for practical and safe medicine delivery systems.
Q6. In self-administered parenteral market, which region is expected to be the largest in next 5 years?
Answer: APAC is expected to witness the highest growth over the forecast period.
Q7. Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.